Introduction
Discogenic back pain is associated with alterations of the disc and abnormal turnover of the disc extracellular matrix. Unlike conventional treatment options, biologic therapeutic approaches aim to stop/retard the degenerative process and to restore healthier discs, by transplantation of a matrix-rich tissue to the damaged disc. SIS or Small Intestine Submucosa, harvested from the porcine small intestine, has been used extensively as a soft tissue augmentation device. 1 SIS promotes cell proliferation/differentiation and induces synthesis of a new tissue structurally and functionally similar to the original damaged tissue. In musculoskeletal applications, SIS has been used to promote tissue regeneration in rotator cuffs, knee ligaments, tendons and menisci. 2 . We hypothesize that such a bioactive scaffold, which contains entrapped growth factors factors such as basic fibroblast growthfactor (bFGF), vascular endothelial cell growth factor (VEGF) and transforming growth factor (TGF Beta), may stimulate the in situ disc cells to proliferate and synthesize a new extracellular matrix, thereby forestalling the depletion of proteoglycans and arresting the degeneration, or even promoting the regeneration, of the disc. The objective of this study investigated the culture of human degenerative disc cells in SIS in terms of cell viability and proliferation, synthesis of glycosaminoglycans (GAGs) and collagen and gene expression.
Methods
Human nucleus pulposus (NP) and annulus fibrosis (AF) cells were isolated from surgical specimens obtained from three patients who underwent surgery for degenerative disease of the lumbar spine. Porcine small intestine submucosa was prepared by DePuy AcroMed (Raynham, MA), processed for disinfection with 0.1% peracetic acid in ethanol, rinsed in distilled water and stored at 4 o C until use. SIS membranes (~ 5 cm 2 x 200 µm thick) were seeded with either nucleus pulposus (NP) cells or annulus fibrosus (AF) cells (4x10 6 cells). Non attached cells were counted in culture medium one day after seeding. The samples were harvested after culturing in 6-well plates for one, two or three months. Two to five replicates of each disc donor cell population were tested in this study. Non-seeded SIS scaffolds incubated in culture medium served as controls. The wet and dry weights of the SIS scaffolds were recorded and the water content was calculated. The cellular metabolic activity was evaluated by a WST-1 assay. For DNA quantification, SIS scaffolds were digested with 20 units/mL papain then asseyed with a PicoGreen DNA Reagent. Aliquots from the papain-digested SIS scaffolds were assayed for glycosaminoglycan content with a dimethylmethylene blue assay. After fixation in 10% formalin, SIS scaffolds were paraffin embedded and sectioned. H&E and toluidine blue staining were performed. Total RNA was isolated from SIS scaffolds using a RNeasy Kit and PCR was carried out with following primers: collagen I, collagen II, collagen X, aggrecan and Sox-9 Human actin was used as the control. PCR products were analyzed by agarose gel electrophoresis. Statistical analysis was performed with a Student t test and p<0.05 was considered significant.
Results
The initial acellular scaffold used in this study consisted of a singlelayered, thin extracellular matrix membrane, on which disc cells were seeded as a suspension. On day one, more than 70% of disc cells attached to the scaffold. Gross appearance of the SIS scaffolds seeded with disc cells changed over time, showing significant folding and shrinkage as compared to the control scaffold. Examination of H&E stained sections of seeded scaffolds revealed clusters of cells in the folded areas, as well as cells present on the surface of the scaffold. After one month, cells appeared mainly on the edges of the scaffold, whereas at later time points cells that migrated throughout the scaffold were observed deeper in the SIS. Large areas of glycosaminoglycans observed on seeded scaffolds indicated the deposition of extracellular matrix, since no similar areas were ever found in control scaffolds and accumulation of cells was associated with these glycosaminoglycansrich areas.
No significant differences were found between the water content of non seeded and seeded scaffolds. Both NP and AF cells cultured in SIS scaffolds remained viable and metabolically active for up to three months. The ratio of metabolic activity/cell number remained constant. Even though all SIS samples initially contained glycosaminoglycans, seeded scaffolds demonstrated a higher GAG content as compared to control SIS. Control scaffolds experienced a massive loss of glycosaminoglycans during the first two months of culture, before reaching a stable low GAG content after 3 months. Significant differences with controls were achieved for AF cells after one and two months of culture (571±51 µg /g vs 338±113 µg /g and 496±97 µg /g vs 236±60 µg /g, respectively). As a matter of interest, NP cells needed two months of culture to reach statistical differences with controls (416±84 µg /g vs 236±60 µg /g). Addition of disc cells to the SIS scaffolds resulted in an increase of the GAG content of up to 200% for AF cells after two months and 180% for NP cells after three months. No difference in collagen content was found between control and scaffolds seeded with either AF cells or NP cells. Deposition of new extracellular matrix components was confirmed by positive gene expression for collagens, aggrecan and Sox-9. Collagen Type I expression was positive in all samples. Collagen Type II and X were positive in most samples, although the signal for type X was weak. Aggrecan expression was positive at one month and then at three months. Expression of Sox-9 was never positive at one month but visible at the two-or three-month time points.
Discussion
We have demonstrated that In vitro, SIS scaffold supported the growth of human degenerative disc cells and provided the necessary biochemical environment and growth factors for a sustained synthesis of GAGs over a three-month period. Positive histology and gene expression confirmed the production of new extracellular matrix components that might restore the biochemical properties and functions of the human intervertebrate disc. NP cells and AF cells differed with respect to their ability to accumulate extracellular matrix components. The highest GAG content was reached with AF cells cultured for two months, while a continuous increase was observed for NP cells. The progressive and significant increase of the GAG content when culturing NP cells suggest that the slow and continuous release of growth factors associated with SIS might have explained the effect on the NP cells. Loss of GAGs from initial SIS scaffold was delayed by synthesis of new glycosaminoglycans by AF cells, and even compensated by synthesis from NP cells.The effect of such growth factors on disc cells was also evidenced by studying their gene expression profile over time. The decrease of Sox-9 expression has been reported to be associated with disc degeneration and decreased collagen type II gene expression. 3 Even though sox-9 was not detected at the early time points, it was detected in the 3-month scaffolds, suggesting a possible regeneration mechanism that would restore a normal gene expression profile of these disc cells. Moreover, the late expression of collagen type X, which has been described as an indication of repair or remodeling of the disc 4 , was observed.
As a conclusion, the ability of annulus cells to synthesize a new matrix whose properties resemble those of the nucleus pulposus demonstrate that regeneration from available in situ cells could take place even if nucleus cells were absent..
